2,217
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Improving Infinium MethylationEPIC data processing: re-annotation of enhancers and long noncoding RNA genes and benchmarking of normalization methods

, , , , , & ORCID Icon show all
Pages 2434-2454 | Received 20 Jun 2022, Accepted 04 Oct 2022, Published online: 10 Nov 2022

References

  • Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016 Aug;17(8):487–500.
  • Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet. 2010 Mar;11(3):204–220.
  • Jeschke J, Collignon E, Fuks F. DNA methylome profiling beyond promoters – taking an epigenetic snapshot of the breast tumor microenvironment. FEBS J. 2015;282(9):1801–1814.
  • Lister R, Pelizzola M, Dowen RH, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009 Nov;462(7271):315–322.
  • The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct;490(7418):61–70.
  • Boyle P, Clement K, Gu H, et al. Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling. Genome Biol. 2012 Oct 3;13(10):R92.
  • Klughammer J, Kiesel B, Roetzer T, et al. The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nat Med. 2018 Oct;24(10):1611–1624.
  • Bock C, Tomazou EM, Brinkman AB, et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol. 2010 Oct;28(10):1106–1114.
  • Bibikova M, Le J, Barnes B, et al. Genome-wide DNA methylation profiling using infinium ® assay. Epigenomics. 2009 Oct;1(1):177–200.
  • Bibikova M, Barnes B, Tsan C, et al. High density DNA methylation array with single CpG site resolution. Genomics. 2011 Oct 1;98(4):288–295.
  • Dedeurwaerder S, Defrance M, Calonne E, et al. Evaluation of the infinium methylation 450K technology. Epigenomics. 2011 Dec 1;3(6):771–784.
  • Dedeurwaerder S, Defrance M, Bizet M, et al. A comprehensive overview of Infinium humanmethylation450 data processing. Brief Bioinform. 2014;15(6):929–941.
  • Nordlund J, Bäcklin CL, Wahlberg P, et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 2013 Sep 24;14(9):r105.
  • Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013 Dec 10;14(10):3156.
  • Dayeh T, Volkov P, Salö S, et al. Genome-Wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 2014 Mar 6;10(3):e1004160.
  • Jeschke J, Bizet M, Desmedt C, et al. DNA methylation–based immune response signature improves patient diagnosis in multiple cancers. J Clin Invest. 2017 Aug 1;127(8):3090–3102.
  • Ochoa-Rosales C, Portilla-Fernandez E, Nano J, et al. Epigenetic link between statin therapy and type 2 diabetes. Diabetes Care. 2020 Feb 7;43(4):875–884.
  • Lee H-S, Park T. The influences of DNA methylation and epigenetic clocks, on metabolic disease, in middle-aged Koreans. Clin Epigenetics. 2020 Oct 15;12(1):148.
  • Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016 Jan 9;8(9):a019505.
  • Pasculli B, Barbano R, Parrella P. Epigenetics of breast cancer: biology and clinical implication in the era of precision medicine. Semin Cancer Biol. 2018 Aug;51:22–35.
  • Jones PA, Issa J-PJ, Baylin S. Targeting the cancer epigenome for therapy. Nat Rev Genet. 2016 Oct;17(10):630–641.
  • Berdasco M, Esteller M. Clinical epigenetics: seizing opportunities for translation. Nat Rev Genet. 2019 Feb;20(2):109–127.
  • Klutstein M, Nejman D, Greenfield R, et al. DNA methylation in cancer and aging. Cancer Res. 2016 Jun 15;76(12):3446–3450.
  • Smith ZD, Meer A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013 Mar;14(3):204–220.
  • Köhler F, Rodríguez-Paredes M. DNA methylation in epidermal differentiation, aging, and cancer. J Invest Dermatol. 2020 Jan 1;140(1):38–47.
  • Ehrlich M. DNA hypermethylation in disease: mechanisms and clinical relevance. Epigenetics. 2019 Dec 2;14(12):1141–1163.
  • Glass JL, Hassane D, Wouters BJ, et al. Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers. Cancer Discov. 2017 Aug;7(8):868–883.
  • Koldobskiy MA, Abante J, Jenkinson G, et al. A dysregulated DNA methylation landscape linked to gene expression in MLL-rearranged AML. Epigenetics. 2020 Aug 2;15(8):841–858.
  • Heyn H, Vidal E, Ferreira HJ, et al. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer. Genome Biol. 2016 Jan 26;17(1):11.
  • Aran D, Sabato S, Hellman A. DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes. Genome Biol. 2013 Mar 12;14(3):R21.
  • Yao L, Shen H, Laird PW, et al. Inferring regulatory element landscapes and transcription factor networks from cancer methylomes. Genome Biol. 2015 May 21;16(1):105.
  • Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009 Jan 7;23(13):1494–1504.
  • Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012 Jun;9(6):703–719.
  • Van Grembergen O, Bizet M, de Bony Ej, et al. Portraying breast cancers with long noncoding RNAs. Sci Adv. 2016 Sep 2;2(9):e1600220.
  • Alsaleh H, Haddrill PR. Identifying blood-specific age-related DNA methylation markers on the illumina methylationEPIC® beadchip. Forensic Sci Int. 2019 Oct;303:109944.
  • Zaimi I, Pei D, Koestler DC, et al. Variation in DNA methylation of human blood over a 1-year period using the illumina methylationEPIC array. Epigenetics. 2018 Nov 2;13(10–11):1056–1071.
  • McEwen LM, Jones MJ, Lin DTS, et al. Systematic evaluation of DNA methylation age estimation with common preprocessing methods and the infinium methylationEPIC BeadChip array. Clin Epigenetics. 2018 Oct 16;10(1):123.
  • Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014 Mar;507(7493):455–461.
  • Moran S, Arribas C, Esteller M. Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics. 2016 Mar;8(3):389–399.
  • Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of infinium DNA methylation beadchip probes. Nucleic Acids Res. 2016;gkw967. DOI:10.1093/nar/gkw967
  • Volders P-J, Anckaert J, Verheggen K, et al. LNCipedia 5: towards a reference set of human long non-coding RNAs. Nucleic Acids Res. 2019 Jan 8;47(D1):D135–9.
  • Zerbino DR, Achuthan P, Akanni W, et al. Ensembl 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D754–61.
  • Rhee I, Bachman KE, Park BH, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002 Apr 4;416(6880):552–556.
  • Talukdar FR, Lima SCS, Khoueiry R, et al. Genome-wide DNA methylation profiling of esophageal squamous cell carcinoma from global high-incidence regions identifies crucial genes and potential cancer markers. Cancer Res. 2021 May 15;81(10):2612–2624.
  • Salas LA, Zhang Z, Koestler DC, et al. Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling. Nat Commun. 2022 Feb 9;13(1):761.
  • Chen J-Q, Salas LA, Wiencke JK, et al. Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes. Clin Epigenetics. 2022 Jan 21;14(1):14.
  • Akhtar-Zaidi B, Cowper-Sal·lari R, Corradin O, et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science. 2012;336(6082):736–739. Internet.
  • Almamun M, Levinson BT, van Swaay AC, et al. Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia. Epigenetics. 2015 Sep 2;10(9):882–890.
  • Sandoval J, Heyn H, Moran S, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 2011 Jun 1;6(6):692–702.
  • Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature. 2011 May 5;473(7345):43–49.
  • Li Y, Zhang Y, Li S, et al. Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer. Sci Rep. 2015 Mar 5;5(1):8790.
  • Li W, Lam MT, Notani D. Enhancer RNAs. Cell Cycle. 2014 Oct 15;13(20):3151–3152.
  • Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet. 2010 Mar;11(3):191–203.
  • De Meyer T, Bady P, Trooskens G, et al. Genome-wide DNA methylation detection by methylcap-seq and infinium humanmethylation450 BeadChips: an independent large-scale comparison. Sci Rep. 2015 Oct 20;5(1):15375.
  • Koch A, Joosten SC, Feng Z, et al. Analysis of DNA methylation in cancer: location revisited. Nat Rev Clin Oncol. 2018 Jul;15(7):459–466.
  • Pidsley R, Zotenko E, Peters TJ, et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016 Dec;17(1):208.
  • Niu L, Xu Z, Taylor JA. RCP: a novel probe design bias correction method for Illumina Methylation BeadChip. Bioinformatics. 2016 Sep 1;32(17):2659–2663.
  • Teschendorff AE, Marabita F, Lechner M, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013 Jan 15;29(2):189–196.
  • Triche TJ, Weisenberger DJ, Van Den Berg D, et al. Low-level processing of Illumina infinium DNA Methylation BeadArrays. Nucleic Acids Res. 2013 Apr;41(7):e90.
  • Marabita F, Almgren M, Lindholm ME, et al. An evaluation of analysis pipelines for DNA methylation profiling using the Illumina HumanMethylation450 BeadChip platform. Epigenetics. 2013 Mar;8(3):333–346.
  • Touleimat N, Tost J. Complete pipeline for infinium ® human methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics. 2012 Jun;4(3):325–341.
  • Pidsley R, Wong CC Y, Volta M, et al. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics. 2013 Dec;14(1):293.
  • Maksimovic J, Gordon L, Oshlack ASWAN. Subset-quantile within array normalization for illumina infinium HUMANMETHYLATION450 BeadChips. Genome Biol. 2012;13(6):R44.
  • Pfister SX, Ashworth A. Marked for death: targeting epigenetic changes in cancer. Nat Rev Drug Discov. 2017 Apr;16(4):241–263.
  • Fortin J-P, Labbe A, Lemire M, et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Int J Med. 2014;17.
  • Batra RN, Lifshitz A, Vidakovic AT, et al. DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation. Nat Commun. 2021 Sep 13;12(1):5406.
  • Huang P, Xu M, Han H, et al. Integrative analysis of epigenome and transcriptome data reveals aberrantly methylated promoters and enhancers in hepatocellular carcinoma. Front Oncol. 2021;11:Internet. DOI:10.3389/fonc.2021.769390.
  • Wilson ER, Helton NM, Heath SE, et al. Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cells. Leukemia. 2021 Dec 6;1;1–11.
  • Dedeurwaerder S, Desmedt C, Calonne E, et al. DNA methylation profiling reveals a predominant immune component in breast cancers. EMBO Mol Med. 2011 Dec;3(12):726–741.
  • Heiss JA, Brenner H. Between-array normalization for 450K data. Front Genet. Internet]. 2015 Mar 10 Available from. http://www.frontiersin.org/Epigenomics_and_Epigenetics/10.3389/fgene.2015.00092/abstract.
  • Price EM, Cotton AM, Lam LL, et al. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin. 2013 Dec;6(1):4.
  • McCartney DL, Walker RM, Morris SW, et al. Identification of polymorphic and off-target probe binding sites on the illumina infinium methylationEPIC BeadChip. Genom Data. 2016 May 26;9:22–24.
  • Sheffield NC, Pierron G, Klughammer J, et al. DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma. Nat Med. 2017 Mar;23(3):386–395.